收藏切换
Research progress on traditional Chinese medicine polysaccharides against chronic obstructive pulmonary disease
收藏切换
Chinese Traditional and Herbal Drugs | 2025, 56(7) : 2604 - 2616
Less
收藏切换
Chinese Traditional and Herbal Drugs | 2025, 56(7): 2604-2616
Research progress on traditional Chinese medicine polysaccharides against chronic obstructive pulmonary disease
Full
LI Yong1, ZHAO Anhui1, BIAN Zhiying1, FANG Jiawei2, RUAN Yi2, TIAN Wenjing1, LIU Sijing2, GUO Jinlin1,2
Affiliations
    1 School of Pharmacy/School of Modern Chinese Medicine Industry, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China;
    2 College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
doi: 10.7501/j.issn.0253-2670.2025.07.033
Outline
收藏切换
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, making the effective treatment of this condition is an urgent medical challenge. Polysaccharides derived from traditional Chinese medicine (TCM) have gained significant attention in COPD therapy due to their immunomodulatory, anti-inflammatory, and antioxidant properties. This study conducted a systematic search of databases, including PubMed, CNKI, and Web of Science, to summarize, categorize, and synthesize clinical trials and preclinical research on the use of these polysaccharides for the treatment of COPD over the past two decades. The analysis indicated that TCM polysaccharides, such as astragalus polysaccharides, lentinan and polysaccharide of Shihu (Dendrobii Caulis), can significantly improve clinical symptoms and respiratory function in COPD patients. These polysaccharides could enhance immune capacity and reduce inflammation levels. The mechanisms of action primarily involve alleviating oxidative stress, modulating immune-inflammatory responses, inhibiting airway remodeling, and regulating gut microbiota. The TCM polysaccharides in the treatment of COPD demonstrates substantial development potential and promising prospects. This not only broadens the application value of polysaccharides in traditional medicine but also provides a significant reference for the development and utilization of TCM polysaccharide resources and the discovery of new drugs for COPD.
traditional Chinese medicine polysaccharide  /  chronic obstructive pulmonary disease  /  clinical application  /  oxidative stress  /  immune-inflammation  /  airway remodeling  /  gut microbiota  /  astragalus polysaccharides  /  lentinan  /  polysaccharide of Dendrobii Caulis
李勇, 赵安慧, 边志影, 方佳伟, 阮燚, 田文静, 刘思静, 国锦琳. 中药多糖抗慢性阻塞性肺病的研究进展. 中草药, 2025 , 56 (7) : 2604 -2616 . DOI: 10.7501/j.issn.0253-2670.2025.07.033
LI Yong, ZHAO Anhui, BIAN Zhiying, FANG Jiawei, RUAN Yi, TIAN Wenjing, LIU Sijing, GUO Jinlin. Research progress on traditional Chinese medicine polysaccharides against chronic obstructive pulmonary disease[J]. Chinese Traditional and Herbal Drugs, 2025 , 56 (7) : 2604 -2616 . DOI: 10.7501/j.issn.0253-2670.2025.07.033
Year 2025 volume 56 Issue 7
48
8
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.07.033
  • Receive Date:2024-10-30
  • Online Date:2026-11-13
Article Data
Affiliations
History
  • Received:2024-10-30
Affiliations
References
Share
https://castjournals.cast.org.cn/joweb/zcy/EN/10.7501/j.issn.0253-2670.2025.07.033
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT